For example, ASXL1 mutation did not predict outcome but only a trend of adverse prognosis of patients with MDS in our cohort and other Chinese population, in contrast, ASXL1 mutation was related to poor prognosis in European patients 12-15. The gene discussed is ASXL1; the disease is myelodysplastic syndrome.